News

Article

NeurologyLive Friday 5 — July 16, 2021

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending July 15, 2021.

Welcome to NeurologyLive's Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive's widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: Peer Exchange: Common Strategies to Manage Advanced Parkinson Disease

In episode 6 of the NeurologyLive Peer Exchange, "Recognizing and Managing Advanced Parkinson Disease," Adolfo Ramirez-Zamora, MD; Joohi Jimenez-Shahed, MD; Aristide Merola, MD, PhD; Michael J. Soileau, MD, discuss different strategies to manage concerns relating to advanced Parkinson disease including patient education.

2: Podcast: Episode 42: The Importance of Sleep for Overall Health

"Mind Moments," brings you an exclusive interview with Raman Malhotra, MD, who discussed the AASM's recent position statement calling for a greater emphasis on sleep health in education, clinical practice, inpatient and long-term care, public health promotion, and the workplace due to sleep's critical role in overall health.

3: NeuroVoices: Yung Chyung, MD, on the Advantages of Apitegromab in Early SMA Treatment

The chief medical officer of Scholar Rock described how the investigational apitegromab aims to fill some of the current unmet needs for patients with spinal muscular atrophy, how a complementary approach with apitegromab can alter and improve the SMA treatment landscape, the upcoming phase 3 trial, and why early administration of therapy is crucial for this patient population.

4: AAN Releases Statement on Ethical Considerations in Dementia Diagnosis and Care

The American Academy of Neurology position statement considers the diagnosis of dementia, problems in decision making, symptoms and behavioral management, and the relationship between dementia care and society.

5: Peers & Perspectives: Dravet Syndrome: Cannabidiol Oral Solution

Elaine C. Wirrell, MD, provides an overview of cannabidiol oral solution for treatment of seizures associated with Dravet syndrome in episode 7 of the NeurologyLive Peers & Perspectives series, "Comprehensive Management of Dravet Syndrome."

–––––––––

In case you missed it: NeurologyLive is once again running our quarterly audience survey! We kindly ask you to share 5 minutes of your time with us in order to help us better understand how you use social media and how we can better serve you across different platforms.

The fourth installment of our webinar series, "The Ever-Changing Face of Multiple Sclerosis," put on in partnership with the Consortium of Multiple Sclerosis Centers, is set for Wednesday, July 21, at 7:00 PM ET. This time, the conversation will focus on the evolving rehabilitation strategies for patients with MS, and will feature Ahmed Obeidat, MD, PhD; Nicholas C. Ketchum, MD; Francois Bethoux, MD, who aim to share their insight into gait and ambulation issues, spasticity and its management, the incorporation of technology into rehabilitation, and the traditional versus nontraditional approaches,

To register for the broadcast for free, click here. To view the on-demand versions of the first 3 programs, click here for our Future Leaders in Neurology section.

Related Videos
2 experts in this video
2 experts in this video
Anna Pace, MD
Michael Levy, MD, PhD, is featured in this series.
Klaus Werner, MD & Alon Ironi
Howard Fillit, MD
© 2024 MJH Life Sciences

All rights reserved.